{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:02:28Z","timestamp":1758819748705},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:00:00Z","timestamp":1146096000000},"content-version":"vor","delay-in-days":5078,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[1992,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The effect of single dose topical nasal therapy with azelastine hydrochloride (azelastine) on the response of nasal airways resistance (NAR) to provocation testing was studied in 36 patients with seasonal allergic rhinitis. Nasal provocation testing (NPT) with histamine or grass pollen was performed after a single dose of azelastine, 0.28 mg to each nostril, or placebo. NAR was assessed by rhinomanometry for 10 hr following NPT. Compared to placebo the NAR response to histamine was inhibited at both 1 and 2 hr following azelastine administration, significant at 1 hr (<jats:italic>P<\/jats:italic> &lt; 0.02) and 2 hr (<jats:italic>P<\/jats:italic> &lt; 0.0001). No such effect was observed in relation to allergen\u2010induced changes in NAR. Azelastine also inhibited numbers of sneezes for up to 10 hr following both histamine NPT (<jats:italic>P<\/jats:italic> &lt; 0.02) and allergen NPT (<jats:italic>P<\/jats:italic> &lt; 0.05), when compared to placebo. Forty\u2010seven per cent of participants experienced bitter or unpleasant taste sensations after azelastine administration but no other unwanted effects were clearly related to azelastine therapy.<\/jats:p>","DOI":"10.1111\/j.1365-2222.1992.tb00182.x","type":"journal-article","created":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T13:22:16Z","timestamp":1146230536000},"page":"642-647","source":"Crossref","is-referenced-by-count":15,"title":["The effect of intranasal azelastine, Rhinolast\u00ae, on nasal airways obstruction and sneezing following provocation testing with histamine and allergen"],"prefix":"10.1111","volume":"22","author":[{"given":"K. E.","family":"THOMAS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"OLLIER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"FERGUSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"DAVIES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"181","article-title":"Inhibition of histamine secretion from rat peritoneal mast cells (RPMC) by azelastine, a novel, orally acting anti\u2010asthmatic agent","volume":"25","author":"Chand N","year":"1983","journal-title":"Pharmacologist"},{"key":"e_1_2_1_3_2","first-page":"161","article-title":"inhibition of secretagogue\u2010induced histamine release from rat peritoneal mast cells in vitro by a novel antiallergic agent 4\u2010(p\u2010chlorobenzyl)\u20102\u2010(hexahydro\u20101\u2010methyl\u20101H\u2010azepin\u20104\u2010yl)\u20101(2HV) phthalazinone hydrochloride (azelastine)","volume":"23","author":"Fields DAS","year":"1981","journal-title":"Pharmacologist"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90311-4"},{"key":"e_1_2_1_5_2","first-page":"317","article-title":"Azelastine inhibits stimulated histamine release from human lung tissue does not alter cyclic nucleotide content","volume":"135","author":"Little MM","year":"1987","journal-title":"Am Rev Resp Dis"},{"key":"e_1_2_1_6_2","first-page":"184","article-title":"Inhibition of IgE mediated passive cutaneous anaphylaxis (PCA) by azelastine in the rat","volume":"73","author":"Diamantis W","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_7_2","first-page":"1184","article-title":"Pharmacological and toxicological properties of azelastine, a novel anti\u2010allergic agent","volume":"31","author":"Zechel HJ","year":"1981","journal-title":"Arzneim-Forsch"},{"key":"e_1_2_1_8_2","first-page":"149","article-title":"Inhibition of release of SRS\u2010A and its antagonism of azelastine (A), an H1\u2010antagonist antiallergic agent","volume":"123","author":"Diamantis W","year":"1982","journal-title":"Pharmacologist"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(85)90386-0"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1988.tb05291.x"},{"key":"e_1_2_1_11_2","first-page":"138","article-title":"The effect of azelastine on the airway response to histamine and methacholine in asthmatic subjects","volume":"2","author":"Rafferty P","year":"1987","journal-title":"Allergolgica et Immunologica Clinica"},{"key":"e_1_2_1_12_2","first-page":"220","article-title":"Effect of azelastine hydrochloride on histamine and allergen induced bronchoconstriction in asthmatic patients","volume":"43","author":"Rafferty P","year":"1988","journal-title":"Thorax"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(86)80090-2"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90082-6"},{"key":"e_1_2_1_15_2","first-page":"144","article-title":"Multicentre trial of azelastine in allergic rhinitis","volume":"73","author":"Perhach J","year":"1884","journal-title":"Immunol"},{"key":"e_1_2_1_16_2","first-page":"392","article-title":"Azelastine (AZ) a new antiallergy agent: efficacy in ragweed hayfever","volume":"55","author":"Connell JT","year":"1986","journal-title":"Ann Allergy"},{"key":"e_1_2_1_17_2","first-page":"528","article-title":"Azelastine in seasonal allergic rhinitis: the Iowa experience","volume":"56","author":"Rhodes BJ","year":"1986","journal-title":"Ann Allergy"},{"key":"e_1_2_1_18_2","first-page":"205","article-title":"Efficacy of azelastine in perennial allergic rhinitis","volume":"79","author":"Meltzer EO","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_19_2","first-page":"308","article-title":"Experiences in the use of E\u20100659 for treatment of allergic rhinitis","volume":"60","author":"Emoto K","year":"1983","journal-title":"Jpn J Clin Exp Med"},{"key":"e_1_2_1_20_2","first-page":"281","article-title":"Azelastine for perennial allergic rhinitis (PAR): clinical and rhinomanometric evaluation","volume":"58","author":"Meltzer EO","year":"1987","journal-title":"Ann Allergy"},{"key":"e_1_2_1_21_2","first-page":"281","article-title":"Efficacy of azelastine (AZ) in perennial allergic rhinitis","volume":"58","author":"Storms WW","year":"1987","journal-title":"Ann Allergy"},{"key":"e_1_2_1_22_2","first-page":"496","article-title":"Studies of the clinical effect of E\u20100659 on so\u2010called vasomotor rhinitis","volume":"29","author":"Fukutake T","year":"1983","journal-title":"Otolaryngology (Japan)"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.2307\/2556170"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb05903.x"},{"key":"e_1_2_1_25_2","volume-title":"Allergic and vasomotor rhinitis; pathophysiological aspects","author":"Mygind N","year":"1987"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1989.tb01070.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(85)90100-9"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.39.9.668"},{"key":"e_1_2_1_29_2","first-page":"115","article-title":"The nasal effects of prostaglandin D2 in non\u2010rhinitic and atopic rhinitic subjects","volume":"20","author":"Walsh S","year":"1990","journal-title":"Clin Exp Allergy"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(84)90095-9"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.2.357"},{"key":"e_1_2_1_32_2","first-page":"75","article-title":"Controlled comparison of a new antihistamine\u2010decongestant combination to its individual components","volume":"45","author":"Falliers CJ","year":"1980","journal-title":"Ann Allergy"},{"key":"e_1_2_1_33_2","first-page":"502","article-title":"Multicentre, double\u2010blind, placebo\u2010controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis","volume":"54","author":"Kemp JP","year":"1985","journal-title":"Ann Allergy"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03171.x"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1990.tb02458.x"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(87)80194-X"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.1992.tb00182.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.1992.tb00182.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T10:11:33Z","timestamp":1698055893000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.1992.tb00182.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1992,6]]}},"alternative-id":["10.1111\/j.1365-2222.1992.tb00182.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.1992.tb00182.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,6]]}}}